Panel votes down heart safety claim for naproxen

February 11, 2014

Federal health experts say that new research is not strong enough to conclude that naproxen, the pain reliever in Aleve and many other medications, is safer on the heart than rival drugs used by millions of Americans to treat aches and pains.

The Food and Drug Administration advisory panel voted 16-9 against the conclusion that naproxen has a lower risk of and stroke compared with similar anti-inflammatory medications like ibuprofen, sold as Advil and in other generic formulations.

Debate about whether one drug in the class is safer than others has waged for more than a decade without a clear answer.

The FDA convened the meeting this week to consider new analyses that apparently show lower heart risks for . But panelists said the data was not conclusive.

Explore further: Red flags on pain reliever safety

Related Stories

Red flags on pain reliever safety

July 19, 2011

For many people, pain relievers are wonder drugs, allowing them to carry on with their lives despite disabling arthritis, for instance, or recurrent headaches. But all pain relievers, whether sold over-the counter (OTC) or ...

Pain reliever naproxen shows anti-viral activity against flu

March 21, 2013

The over-the-counter anti-inflammatory drug naproxen may also exhibit antiviral activity against influenza A virus, according to a team of French scientists. The finding, the result of a structure-based investigation, is ...

US panel wants changes to Avandia safety measures (Update)

June 6, 2013

US government health experts are recommending changes to safety restrictions on former blockbuster diabetes pill Avandia, in light of a new analysis suggesting that the drug may not increase the risk of heart attack as previously ...

Recommended for you

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.